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Abstract
Methylmalonic aciduria (MMA) cblB type is caused by mutations in the MMAB gene, which 
codes for the enzyme adenosine triphosphate (ATP): cobalamin adenosyltransferase (ATR). This 
study reports differences in the metabolic and disease outcomes of two pairs of siblings with 
MMA cblB type, respectively harbouring the novel changes p.His183Leu/p.Arg190dup (P1 and 
P2) and the previously described mutations p.Ile96Thr/p.Ser174fs (P3 and P4). Expression 
analysis showed p.His183Leu and p.Arg190dup to be destabilizing mutations. Both were 
associated with reduced ATR stability and a shorter half-life than wild-type ATR. Analysis of 
several parameters related to oxidative stress and mitochondrial function showed an increase in 
reactive oxygen species (ROS) content, a decrease in mitochondrial respiration and changes in 
mitochondria morphology and structure in patient-derived fibroblasts compared to control cells. 
The impairment in energy production and the presence of oxidative stress and fission of the 
mitochondrial reticulum suggested mitochondrial dysfunction in cblB patients’ fibroblasts. The 
recovery of mitochondrial function should be a goal in efforts to improve the clinical outcome of 
MMA cblB type.
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ATP:cob(I)alamin adenosyltransferase (ATR, E.C.2. 5.1.17) is involved in coenzyme B12 
metabolism, converting reduced cob(I)alamin to adenosylcobalamin. The latter is the active 
cofactor of methylmalonyl-CoA mutase (MUT, EC 5.4.99.2), which catalyses the reversible 
rearrangement of methylmalonyl-CoA to succinyl-CoA during the catabolism of branched-
chain amino acids, odd-chain fatty acids and cholesterol. Mutations in the human MMAB 
gene coding for ATR are responsible for methylmalonic aciduria (MMA) cblB type (OMIM 
#607568). Patients with MMA cblB type suffer either a severe, early-onset form of the 
disease, with neonatal ketoacidosis, lethargy, failure to thrive and encephalopathy, or a 
milder late-onset form usually diagnosed during infancy that has a less serious neurological 
outcome (1).
To date, 32 different mutations have been identified in the MMAB gene in cblB patients 
(HGMD® Professional Release 2013.4). Several of these have been functionally analysed 
and their kinetic parameters determined in prokaryotic and eukaryotic expression systems. 
These studies have revealed the existence of mutants with reduced substrate and cofactor 
affinity (p.R191W) (2), and with negligible activity and presumed instability in vivo 
(p.R186W, p.R190H and p.E193K) (3), as well as destabilizing mutations that retain some 
residual activity (4).
Mitochondrial dysfunction is involved in a number of human genetic diseases, including 
inherited metabolic problems (5–7). In MMA, mitochondrial impairment occurs through the 
combination of the specific inhibition of mitochondrial enzymes, the inhibition of 
respiratory complexes, transport inhibition, the restriction of certain substrates for the 
tricarboxylic acid (TCA) cycle, and oxidative damage (8, 9). In fact, in MMA, the 
mitochondrial functional impairment observed in different organs and fibroblasts from 
patients, and in mouse models, has been proposed to be partly responsible for increased 
intracellular reactive oxygen species (ROS) levels leading to oxidative stress (7, 9–11). 
Genes involved in controlling oxidative stress might therefore act as phenotype modifiers, 
helping to explain the different disease presentations in patients with identical genotypes, as 
described in oxidative phosphorylation (OXPHOS) disorders (12). The aim of the present 
study was to determine the pathogenic mechanisms of action of two new changes, c.548A>T 
and c.568_570dup, detected in a patient identified in an expanded newborn screening 
program. Mitochondrial function in cells from two pairs of cblB siblings harbouring either 
the new changes, or the previously described changes c.287T>C and c.584GA was also 
examined.
Materials and methods
The patients examined were two sets of siblings (P1 and P2; P3 and P4). P1 was identified 
by expanded newborn screening; a diagnosis of MMA was performed by gas 
chromatography-mass spectrometry (GC-MS) analysis of organic acids in urine. P2 was 
identified by the family genetic study and showed a slight increase in urine methylmalonic 
acid (Table 1). P3 and P4 have been previously described (4, 11). Control fibroblasts 
(GM09503, GM08680, GM5756, GM8429 and GM5381) were obtained from the NIGMS 
Human Genetic Cell Repository (Coriell Institute for Medical Research, NJ). The present 
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study was approved by the Ethics Committees of the Universidad Autónoma de Madrid. 
Written permission to perform genetic studies was provided by the patients’ parents.
Human ATR protein and p.H183L (c.548A>T) and p.R190dup (c.568_570dup) mutants 
were expressed in Escherichia coli; the purification, ATR specific activity and KM values 
were assayed as described (4). The stability of the wild-type and p.H183L and p.R190dup 
proteins was measured by incubation at 27°C or 37°C. Soluble supernatants were incubated 
at 27°C or 37 °C and aliquots were removed at different times for sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). Immunodetection was performed using 
anti-ATR antibody diluted 1:1000 (ProteinTech Group Inc., Chicago, IL). Mitochondria 
isolation from fibroblasts was performed using anti-TOM22 MicroBeads (Miltenyi Biotec, 
Bergisch Gladbach, Germany).
ROS assays were performed in fibroblasts from three controls (GM9503, GM8680 and 
GM5756) and from all patients, as described (11).
For bioenergetic analysis, control and patient-derived fibroblasts (5 × 104 each)were seeded 
per well in 24-well microplates and incubated with Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with glucose or galactose (4.5 g/l, DMEM-Glu or DMEM-Gal) 
overnight at 37°C. Cells were then washed with phosphate buffered saline (PBS); 700 µl of 
DMEM-Glu or DMEM-Gal without bicarbonate were added and the plates incubated at 
37°C for 1 h. Modulating compounds such as oligomycin (OL, 6 µM), carbonyl cyanide 4-
(trifluoromethoxy) phenyl-hydrazone (FCCP, 50 µM), rotenone (RO, 1 µM) and antimycin 
A (AT, 1 µM) were used to assess the bioenergetic profile. Oxygen consumption rate (OCR) 
was measured using a Seahorse XF24 Extracellular Flux Analyser (Seahorse Bioscience, 
Billerica, MA). The calibration plate for these compounds was prepared according to the 
manufacturer’s protocol.
For mitochondrial morphology, 100,000 fibroblasts were seeded on a 10 mm glass coverslip 
and incubated with MEM at 37°C overnight. Cells were then incubated with 500 nM 
Mitotracker® Red CM-H2Ros probe (Life Technologies, Grand Island, NY) at 37°C for 40 
min, and fixed in 10% formalin at room temperature for 20 min. Cells were washed with 
PBS and mounted facing downwards in mounting medium on a microscope slide. Images 
were taken using an Axiovert200 inverted microscope (Zeiss, Jena, Germany; magnification 
×63) equipped with a DsRED filter.
For electron microscopy, fibroblasts were fixed for 1 h in the culture plates with 4% 
paraformaldehyde and 2% glutaraldehyde. Pellets were dehydrated and embedded in Epon 
resin.
Results
P1, classified as belonging to MMA cblB type by somatic cell complementation assay, is 
clinically asymptomatic and follows a disease management plan to avoid metabolic crises. 
His sibling, P2, is asymptomatic. Notably, P2-derived fibroblasts showed a [14C]-propionate 
uptake incorporation close to normal, which decreased significantly when subjected to heat 
shock at 42°C (Fig. 1a). The levels of mitochondrial ATR protein have been assayed and 
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only some traces of immunoreactive protein could be detected in P1 and P2 patients-derived 
fibroblasts (data not shown).
Genetic analysis revealed the presence of two novel mutations in exon 7 in P1 and P2; one 
exonic paternal change probably leading to a missense mutation p.H183L (c.548A>T), and 
one maternal small in-frame duplication, p.R190dup (c.568_570dup). Both changes were 
absent in the Exome Variant database (evs.gs.washington.edu). They were classified as 
‘probably damaging’ by PolyPhen2 (genetics.bwh.harvard.edu/pph2) and SIFT 
(sift.jcvi.org/). No other changes or copy number variations were found after promoter 
sequencing and analysis using a customized high-resolution comparative genomic 
hybridization assay (Metaboloarray®, Agilent, SantaClara, CA) (13).
ATR activity was measured, and the KM for the substrates, adenosine triphosphate (ATP) 
and hydroxocobalamin (OHCbl) were determined using E. coli cell lysates expressing wild-
type or mutant proteins. An approximately 75-fold reduction in specific activity was seen 
compared to the wild-type in the crude extract of bacteria expressing p.His183Leu. The 
purification yield was ~100-fold higher for wild-type vs p.His183Leu. The kinetic data on 
purified ATR showed that the p.His183Leu possessed specific activities indistinguishable 
within experimental variation (0.21±0.01 µmol/mg/min) than the wild type (0.23±0.01 
µmol/mg/min). The KMATP (5.1±1.4 µM) and KMOHCbl (0.71±0.56 µM) values for this 
mutant were similar to those of wild type (KMATP =6.2±1.3 µM and KMOHCbl =1.7±0.4 
µM). The p.Arg190dup mutant did not show detectable activity in crude extracts and could 
not be purified.
The relative half-life of p.His183Leu mutant at 37°C was ~50% that of wild-type (2.5 vs 5.4 
h). At 27°C, however, p.His183Leu showed a marked increase in stability (7.6 vs 6.1). As 
expected, the p.Arg190dup was highly unstable and could not be examined under any 
conditions.
Flow cytometry showed a significant increase of ROS content in P1 cells and a moderate 
increase in P2 cells compared to control fibroblasts. P3 cells also showed a greater increase 
in ROS content than P4 cells (Fig. 1b).
For bioenergetic profile OL, FCCP, RO and AT were sequentially added to the cells and the 
fundamental parameters of mitochondrial function obtained are represented in Fig. 2a. O2 
consumption by fibroblasts revealed that cells grown in DMEM-Glu (Fig. 2b) or DMEM-
Gal (Fig. 2c) had similar bioenergetic profiles. OCR was reduced in all patient-derived 
fibroblasts incubated in either medium, with a shift observed towards higher values in 
control and patient fibroblasts grown in DMEM-Gal; indeed, these reached control levels in 
P2 and P4. This shift is due to an increase in the aerobic production of ATP in the absence 
of glucose. The basal respiratory rates were markedly lower in P1-, P2- and P3-derived 
fibroblasts compared to controls. The maximum OCR after the injection of FCCP into 
DMEM-Glu was lower in patients’ fibroblasts (Fig. 2b), and was doubled in all fibroblasts 
grown in DMEM-Gal (Fig. 2c). A reduction in OCR was observed after the addition of OL. 
The difference between basal OCR levels and post-OL addition represents the effect of 
ATP-linked respiration. In the DMEM-Glu medium, a fall in ATP-linked respiration was 
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observed in all patient-derived fibroblasts compared to controls, especially in P1 (Fig. 2b). 
In DMEM-Gal, ATP-linked respiration was higher in all patient-derived fibroblasts, 
especially in P4 (Fig. 2c).
Marked fission of the mitochondrial reticulum was seen in all patient-derived fibroblasts, 
and mitochondria were seen to gather around the perinuclear area in P3 cells. Compared to 
controls, a significantly increased proportion of grain-like structures were seen in P1, P2 and 
P3 cells and to a lesser extent in P4 (Fig. 3a and b). In addition, cblB fibroblasts presented a 
reduced number of mitochondria and had a distinct mitochondria morphology including a 
marked decrease in size, a striking lack of cristae and a rarefaction of matrix density 
compared to controls (Fig. 3c).
Discussion
The functional analysis data reported herein suggest that the patient-associated changes 
p.His183Leu and p.Arg190dup are destabilizing mutations. Both changes were associated 
with reduced ATR stability and half-life, as described for other cblB mutations such as 
p.Ile96Thr and p.Arg191Trp (4). p.Arg190dup is a severely destabilizing mutation with 
concomitant greatly reduced ATR activity; p.His183Leu has a milder effect. The results 
suggest that p.His183Leu might be a misfolding mutation with low residual activity in 
bacterial crude extract; the purified mutant enzyme exhibits a specific activity, KMATP and 
KMOHCbl values that are within the wild-type range.
Other evidence suggest that p.His183Leu and p.Arg 190dup are folding mutations including 
the [14C]-propionate incorporation results under basal and stress conditions. While P1 
showed lower propionate uptake than the controls under basal conditions, P2 cells only 
showed a propionate pathway defect. The present results are consistent with the idea that 
protein instability under physiological stress is indicative of a high risk of metabolic 
decompensation during illness, especially when fever is present, as described (14). 
Differences in the propionate pathway in P1 and P2 cells are probably explained by changes 
in the expression of proteins involved in the protein quality control system.
In all patient-derived fibroblasts, ROS content, the bioenergetic profile and mitochondrial 
structure were markedly different compared to those of control cells. The mitochondrial 
reserve capacity of the patients’ fibroblasts was reduced, a problem known to occur in short-
chain acyl-CoA dehydrogenase disorder (SCAD) in the presence of destabilizing mutations 
(15). Moreover, the present results reflect significant differences in clinical outcome 
between siblings with the same genotype; P2 and P4, who had better clinical outcomes than 
their respectively siblings P1 and P3, appeared to suffer less mitochondrial dysfunction.
Grain-like structures have been related to mitochondrial fission, a mechanism involved in 
the maintenance of mitochondrial function and the preservation of the mitochondrial 
genome, but also in pre-apoptotic events (16). These grain-like structures were observed in 
all four patient-derived fibroblasts. The marked structural modification we report in cblB 
mitochondria may be correlated with a decrease in the efficiency of oxygen reduction and 
ATP generation and an increase in ROS production. In addition, laminar bodies and 
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autophagosomes engulfing mitochondria were observed in cblB cells suggesting that 
autophagy is characterized by a selective mitophagy. These promising results will be 
followed up with further studies.
The improvement of mitochondrial dysfunction has been proposed as a new therapeutic goal 
in several human disorders. Treatment of these pathologies is not straightforward, but would 
probably involve combinations of conventional and novel pharmacological treatments plus 
nutritional interventions, including the possible consumption of antioxidants to reduce the 
ROS content in specific tissues and organs (17).
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Fig. 1. 
[14C]-Propionate incorporation and intracellular ROS content in control- and patient-derived 
fibroblasts. (a) [14C]-Propionate incorporation was performed by incubation of dermal 
fibroblasts at 37°C or 42°C in the absence of hydroxocobalamin (OHCbl) to provide an 
indirect quantification of adenosyltransferase (ATR) activity. Results are the means±SD of 
three independent experiments (*p<0.05). (b) Intracellular ROS content of control and 
patients’ fibroblasts. Cells were incubated with the H2DCFDA fluorescence probe, and ROS 
levels assessed by flow cytometry. The x-axis represents patient cell lines and the y-axis the 
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fluorescence levels. Control value was determined as the mean of data from the three control 
cell lines. Data are the mean±SD of five independent experiments, each performed in 
triplicate. Data were analysed by analysis of variance (ANOVA; using spss software) with 
Bonferroni correction (*p<0.05, **p<0.01).
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Fig. 2. 
Bioenergetic profile of control- and patient-derived fibroblasts. (a) The fundamental 
parameters of mitochondrial function: basal respiration, adenosine triphosphate (ATP) 
turnover, proton leak, and maximal respiration, or spare respiratory capacity. (b) and (c) 
Bioenergetic profile of patients’ and controls’ fibroblasts cultured in two different kinds of 
media. Cells were incubated with DMEM supplemented with glucose (b) or galactose (c) 
and the oxygen consumption rate (OCR) profile in each case after the addition of 
oligomycin, carbonyl cyanide 4-(trifluoromethoxy) phenyl-hydrazone (FCCP), rotenone and 
antimycin A was measured. Data are the mean±SD of three independent experiments, each 
performed in triplicate. Further analysis to rescue the phenotype after MMAB 
complementary DNA (cDNA) correction will be performed in the near future.
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Fig. 3. 
Mitochondrial morphology and ultrastructure of control- and patient-derived fibroblasts. (a) 
Representative images of mitochondrial morphology of control and patients’ fibroblasts (P1, 
P2, P3 and P4). Cells labelled with MitoTracker®Red CM-H2Ros revealed two distinct 
phenotypes: thread-like (control) and grain-like (P1, P2, P3 and P4), the latter associated 
with mitochondrial fission. (b) Quantification after MitoTracker®Red CM-H2Ros label of 
the mitochondrial phenotypes observed in three independent experiments (each bar 
represents a minimum of 40 images containing a minimum of 2–3 cells). The results 
represent the mean±SD of three independent experiments. (c) Representative electron 
micrographs of control-and patient-derived fibroblasts. Healthy control mitochondria 
contained groups of parallel cristae, which often extended through the entire body of the 
organelle and presented a dense mitochondrial matrix. On the contrary, cblB mitochondria 
had a distinct morphology indicating changes in mitochondria structure. Bars: 200 nm.
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ke
 a
nd
 w
ith
ou
t c
ob
al
am
in
 in
jec
tio
ns 
du
rin
g 3
 ye
ars
. U
rin
e M
MA
 ex
cre
tio
n v
ari
ed
 be
tw
een
 53
 an
d 9
2 m
mo
l/m
ol 
cre
at 
(N
V:
 <1
5).
 A
mi
no
 ac
ids
 in
 pl
asm
a a
nd
 ur
ine
; 
pl
as
m
a 
vi
ta
m
in
 B
12
 a
nd
 m
et
hy
lc
itr
at
e 
in
 u
rin
e 
w
er
e 
in
 th
e 
co
nt
ro
l r
an
ge
. O
nl
y 
m
ild
 in
cr
ea
se
s o
f C
3-
ca
rn
iti
ne
 w
er
e 
de
te
ct
ed
 (1
.07
–2
.24
 µm
ol/
l; N
V:
 0.
15
–0
.89
).
b [
14
C]
-P
ro
pio
na
te 
up
tak
e (
nm
ol/
10
 h/
mg
 pr
ote
in)
 w
ith
ou
t/w
ith
 (−
/+)
 hy
dro
xo
co
ba
lam
in.
c M
ut
at
io
ns
 a
cc
or
di
ng
 to
 N
M
_0
52
84
5.
3.
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